Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.

Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses. Proc Natl Acad Sci U S A (1987) 1.13

Uterine adenocarcinoma with feline leukemia virus infection. Lab Anim Res (2011) 0.78

Unrecognized "AIDS" in Monkeys, 1969-1980: Explanations and Implications. Am J Public Health (2016) 0.75

HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis. Yale J Biol Med (1988) 0.75

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med (2010) 12.08

Does housestaff discontinuity of care increase the risk for preventable adverse events? Ann Intern Med (1994) 10.29

Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science (1985) 9.27

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science (1985) 8.53

Cyclin activation of p34cdc2. Cell (1990) 6.87

Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med (2010) 6.38

Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA (1991) 6.28

RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell (1995) 5.73

Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell (1986) 5.35

The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol (1992) 5.30

Male circumcision: an acceptable strategy for HIV prevention in Botswana. Sex Transm Infect (2003) 5.26

Physician reporting compared with medical-record review to identify adverse medical events. Ann Intern Med (1993) 4.60

Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol (1993) 4.20

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med (2000) 4.14

The structure of histone H1 and its location in chromatin. Nature (1980) 4.09

Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med (1985) 4.00

Extended high viremics: a substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection. AIDS (2011) 3.95

Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science (1985) 3.81

Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science (1985) 3.74

Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science (1968) 3.67

Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One (2009) 3.66

Spectrum of asthma in children. 3. Psychological and social components. Br Med J (1973) 3.44

Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest (1994) 3.31

Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med (1990) 3.31

A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science (1986) 3.20

Antigens encoded by the 3'-terminal region of human T-cell leukemia virus: evidence for a functional gene. Science (1984) 3.20

Proposal for naming host cell-derived inserts in retrovirus genomes. J Virol (1981) 3.18

Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science (1994) 3.10

Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem (1991) 3.06

A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science (1985) 3.05

Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med (1995) 3.03

Rapid classification of positive blood cultures. Prospective validation of a multivariate algorithm. JAMA (1992) 3.02

Effect of race on the presentation and management of patients with acute chest pain. Ann Intern Med (1993) 3.00

Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120. J Virol (1989) 3.00

Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr (2008) 2.93

Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein. Proc Natl Acad Sci U S A (1977) 2.93

Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework. Lancet (2000) 2.87

Heterogeneity of therapeutic responses in asthma. Br Med Bull (2000) 2.86

Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J Virol (1993) 2.80

HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science (1996) 2.79

Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet (1997) 2.71

HTLV-III in symptom-free seronegative persons. Lancet (1984) 2.71

Participation of core histone "tails" in the stabilization of the chromatin solenoid. J Cell Biol (1982) 2.68

Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res Hum Retroviruses (1990) 2.67

Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein. J Virol (1990) 2.60

Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol (1991) 2.57

The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J Virol (1992) 2.51

Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol (1987) 2.50

Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. Science (1983) 2.48

Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One (2010) 2.48

Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet (1986) 2.48

Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax (1997) 2.46

A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med (1988) 2.46

Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion (1985) 2.45

Retracted Mutations at more than one locus may be involved in cystic fibrosis--evidence based on first-cousin data and direct counting of cases. Am J Hum Genet (1983) 2.45

Patient and house officer attitudes on physician attire and etiquette. JAMA (1987) 2.44

Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol (2003) 2.40

Prediction of the need for intensive care in patients who come to the emergency departments with acute chest pain. N Engl J Med (1996) 2.39

A seronegative case of HIV-1 subtype C infection in Botswana. Clin Infect Dis (2007) 2.39

Synthesis and anti-inflammatory effect of chalcones and related compounds. Pharm Res (1998) 2.36

Horizontal transmission of feline leukaemia virus. Nature (1973) 2.34

A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. Nature (1988) 2.33

Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science (1986) 2.33

Roles of H1 domains in determining higher order chromatin structure and H1 location. J Mol Biol (1986) 2.27

Subcellular localization of the product of the long open reading frame of human T-cell leukemia virus type I. Science (1985) 2.25

Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J Virol (1993) 2.21

Covalent structure of human haptoglobin: a serine protease homolog. Proc Natl Acad Sci U S A (1980) 2.21

Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome. Proc Natl Acad Sci U S A (1988) 2.20

The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage. J Virol (1991) 2.18

Mother-to-child transmission of HIV-1 in Congo, central Africa. Congolese Research Group on Mother-to-Child Transmission of HIV. AIDS (1994) 2.18